课题基金 / 基金详情

Development of Novel Polar MAO B Inhibitors for the Treatment of Epithelial Barrier Diseases

Development of Novel Polar MAO B Inhibitors for the Treatment of Epithelial Barrier Diseases
开发用于治疗上皮屏障疾病的新型极性 MAO B 抑制剂
批准号:
308166
负责人:
Putnins Edward E
金额:
$11.66万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2014
资助国家:
加拿大
项目状态:
已结题
起止时间:
2014-02-01 至 2015-02-01

项目摘要

项目成果

Putnins Edward E的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Loss of epithelial barrier integrity is common to many oral and gastrointestinal diseases including ulcerative colitis, periodontitis, and diarrheal diseases. Putnins et al. have demonstrated that monoamine oxidase (MAO) B, a pro-oxidative enzyme, is incr
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Periodontal Disease Pathogenesis by the Effects of Novel Monoamine Oxidase B Inhibitors
  • 批准号:
    473042
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    Putnins Edward E
  • 依托单位:
Regulation of Periodontal Disease Pathogenesis by the Effects of Novel Monoamine Oxidase B Inhibitors
  • 批准号:
    456415
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2021
  • 负责人:
    Putnins Edward E
  • 依托单位:
Protection and Regulation of Oral and Gastrointestinal Mucosal Epithelial Barriers by MAO B Inhibitors and Their Novel Polar Derivatives
  • 批准号:
    253591
  • 项目类别:
    Operating Grants
  • 资助金额:
    $47.55万
  • 财政年份:
    2012
  • 负责人:
    Putnins Edward E
  • 依托单位:
Protection and Regulation of Oral and Gastrointestinal Mucosal Epithelial Barriers by MAO B Inhibitors and Their Novel Polar Derivatives
  • 批准号:
    250225
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2011
  • 负责人:
    Putnins Edward E
  • 依托单位:
海外基金